Genotype-phenotype correlations in tuberous sclerosis: who and how to treat.
Goh
Suzanne
S
Department of Neurology, University of California, San Francisco, San Francisco, CA.
Weiss
William A
WA
Department of Neurology, University of California, San Francisco, San Francisco, CA.
D000596:Amino Acids / Q000378:metabolism; D000075906:Chemokine CCL26; D019742:Chemokines, CC / Q000235:genetics*; D002885:Chromosomes, Human, Pair 16 / Q000235:genetics; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D003062:Codon / Q000235:genetics; D015536:Down-Regulation; D005110:Extracellular Space / Q000378:metabolism; D020558:GTP Phosphohydrolases / Q000235:genetics; D005838:Genotype; D006801:Humans; D010641:Phenotype; D017354:Point Mutation / Q000235:genetics; D011494:Protein Kinases / Q000378:metabolism; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases; D014402:Tuberous Sclerosis / Q000188:drug therapy* / Q000235:genetics*; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins / Q000235:genetics*
D000596:Amino Acids; C120429:CCL26 protein, human; D000075906:Chemokine CCL26; D019742:Chemokines, CC; D003062:Codon; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins; D011494:Protein Kinases; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020558:GTP Phosphohydrolases